Correction to "Aggressive Disease and Poor Clinical Outcome in CEBPα-Mutated Acute Myeloid Leukemia Patient". [PDF]
europepmc +1 more source
Curcumin and Acute Myeloid Leukemia: Synergistic Effects with Targeted Therapy. [PDF]
Badagliacca R +5 more
europepmc +1 more source
Patient and Family Demographics in the Momcology Pediatric Cancer Patient Advocacy Organization
ABSTRACT Background Momcology is a US‐based patient advocacy organization that provides support for families of children with cancer. This study describes Momcology for researchers by detailing the demographic, clinical, and socioeconomic (socioeconomic status [SES]) data within its registry and comparing it to the National Surveillance, Epidemiology ...
Ryan Salama +6 more
wiley +1 more source
An Account of Acute Myeloid Leukemia Complicating Pregnancy and Literature Review. [PDF]
Nemeti G +10 more
europepmc +1 more source
TTLL4 glutamyltransferase is a therapeutic target for NPM1-mutated Acute Myeloid Leukemia [PDF]
Humaira Ilyas +6 more
openalex +1 more source
Determining Preclinical Safety of Aclarubicin in Pediatric Malignancies
ABSTRACT Background Anthracyclines are among the most effective chemotherapeutic agents used to treat pediatric malignancies. However, their clinical use is limited by dose‐dependent toxicities, particularly cardiotoxicity and secondary malignancies.
Darleen S. Tu +15 more
wiley +1 more source
Infantile Acute Myeloid Leukemia Presenting As Intussusception: A Case Report and Review of the Literature. [PDF]
Gu Y +3 more
europepmc +1 more source
VIP, a novel phagocytosis checkpoint in TP53-mutated Acute Myeloid Leukemia [PDF]
Zihan Chen +5 more
openalex +1 more source
IKAROS Associated Immunodeficiency and Thrombotic Thrombocytopenic Purpura
ABSTRACT Pathogenic variants in IKZF1 (IKAROS) are linked to immunodeficiency, malignancy, and immune dysregulation. We describe a family with a rare IKZF1 variant presenting with humoral immunodeficiency and thrombotic thrombocytopenic purpura (TTP). A non‐consanguineous family was clinically monitored; clinical, immunological, and genetic data (exome
Ilia Spivak +7 more
wiley +1 more source
Real-world treatment and utilization of venetoclax for incident acute myeloid leukemia in a Medicare population. [PDF]
Roth JA +9 more
europepmc +1 more source

